The analysis focused on recurrent CNVs with at least three identified carriers, but for the established breast and/or ovarian cancer susceptibility genes, BRCA1, BRCA2, PALB2, TP53, ATM, RAD51C and CHEK2, all observed CNVs were evaluated further. This evidence concerns the gene CHEK2 and ovarian cancer.